Three‐year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus‐eluting stents: Insights from the rapamycin‐eluting stent evaluated at rotterdam cardiology hospital—(RESEARCH) registry
Authors:
- Neville KukrejaNKNeville Kukreja
- Patrick W. SerruysPSPatrick W. Serruys
- 29 October 2007
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 70 (5) , 635-639
Abstract
Background: We previously reported that the 1‐year survival‐free from target lesion revascularization was 97.4% in patients with chronic total occlusion (CTO) treated with sirolimus‐eluting stents (SES). There are currently no long‐term results of the efficacy of SES in this subset of lesions. We assessed the 3‐year clinical outcomes of 147 patients with CTO treated with either SES or bare metal stents (BMS). Methods and Results: A total of 147 (BMS = 71, SES = 76) patients were included. Four patients died in the BMS group while five patients died in the SES group, P = 0.8; two myocardial infarctions occurred in both groups, P = 0.9; and target vessel revascularization was performed in nine patients in the BMS and seven in the SES group, P = 0.5. The cumulative event‐free survival of MACE was 81.7% in BMS group and 84.2% in SES group, P = 0.7. Two patients of the SES group had a coronary aneurism at 3‐year angiographic follow‐up. Conclusions: The use of SES was no longer associated with significantly lower rates of target vessel revascularization and major adverse cardiac events in patients with CTOs after 3 years of follow‐up compared with BMSs.Keywords
This publication has 14 references indexed in Scilit:
- Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II)Circulation, 2006
- Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting StentsCirculation, 2006
- Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: Insights from a systematic overview of randomized trials in light of the drug-eluting stent eraAmerican Heart Journal, 2006
- Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusionsEuropean Heart Journal, 2005
- Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusionsThe American Journal of Cardiology, 2005
- Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stentsJACC, 2004
- Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusionsJACC, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002